Tortoise Investment Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $223K | Buy |
2,136
+1
| +0% | +$104 | 0.02% | 210 |
|
|
2025
Q1 | $249K | Hold |
2,135
| – | – | 0.03% | 190 |
|
|
2024
Q4 | $181K | Hold |
2,135
| – | – | 0.02% | 234 |
|
|
2024
Q3 | $192K | Hold |
2,135
| – | – | 0.02% | 230 |
|
|
2024
Q2 | $172K | Hold |
2,135
| – | – | 0.02% | 232 |
|
|
2024
Q1 | $170K | Hold |
2,135
| – | – | 0.02% | 237 |
|
|
2023
Q4 | $170K | Hold |
2,135
| – | – | 0.02% | 228 |
|
|
2023
Q3 | $149K | Hold |
2,135
| – | – | 0.02% | 227 |
|
|
2023
Q2 | $153K | Hold |
2,135
| – | – | 0.02% | 226 |
|
|
2023
Q1 | $132K | Hold |
2,135
| – | – | 0.02% | 235 |
|
|
2022
Q4 | $165K | Hold |
2,135
| – | – | 0.03% | 203 |
|
|
2022
Q3 | $95K | Buy |
2,135
+825
| +63% | +$36.7K | 0.02% | 253 |
|
|
2022
Q2 | $50K | Hold |
1,310
| – | – | 0.01% | 301 |
|
|
2022
Q1 | $54K | Hold |
1,310
| – | – | 0.01% | 292 |
|
|
2021
Q4 | $49K | Buy |
+1,310
| New | +$49K | 0.01% | 297 |
|